Search Results < Cardiovascular Medicine

46 results

News
Researchers Are Testing Paxlovid as a Treatment for Long COVID
Long COVID currently affects millions of people in the U.S. Symptoms can include brain fog, tremors, sleep disorders, and shortness of breath. The National Institutes of Health (NIH) and other academic medical centers recently launched clinical trials aimed at finding treatments for long COVID. Researchers think that there may be different causes of long COVID symptoms in different people, which is why they are conducting different clinical trials in many centers around the country.
Source: Verywell Health
22 Aug 2023
News
Shockwave Begins First All-Female Study Of Coronary Interventions
The EMPOWER CAD trial will evaluate Shockwave’s intravascular lithotripsy system in female patients undergoing a percutaneous coronary intervention for coronary artery disease.
Source: Medtech Insight
26 Jul 2023
News
What is ‘long vax’? Symptoms linked to COVID-19 shot baffle docs
Researchers say long vax could be due to an immune overreaction to the Covid protein.
Source: New York Post
6 Jul 2023
News
Rare link between coronavirus vaccines and Long Covid–like illness starts to gain acceptance
Studies probe unusual cases of neurologic complications, blood pressure swings, and other side effects.
Source: Science
3 Jul 2023
News
EHR Nudges a Bust for Boosting Guideline-Directed Meds in Acute HF: PROMPT-AHF
A system of personalized alerts did not improve discharge prescriptions for guideline-directed medical therapy for patients hospitalized with heart failure.
Source: Medscape
6 Jun 2023
News
Shockwave Medical Launches New Coronary IVL Catheter Internationally and Enrolls First Patient in All-Female Empower Study
The first patient has been enrolled in EMPOWER CAD, the first prospective, all-female study of percutaneous coronary intervention.
Source: Shockwave Medical, Inc.
15 May 2023
News
Evidence-Based Medical Therapies for Heart Failure: PROMPT-AHF Trial
Tariq Ahmad, MD, MPH, will present a late-breaking clinical trial during the 2023 European Society of Cardiology Heart Failure Association annual meeting.
6 May 2023
News
Draft Guidance Reflects FDA’s Thinking Around Decentralized Trials
The cardiology community must recognize that this will change how trials are done in the next decade, Harlan Krumholz says.
Source: TCTMD
4 May 2023
News
Prevención de accidentes cerebrovasculares: CREST-2
El Dr. Carlos Mena-Hurtado recibió un premio rally del centro de coordinación clínica por el liderazgo excepcional en el ensayo CREST-2.
2 May 2023
News
Yale receives clinical coordinating center rally award for CREST-2 trial
Carlos Mena-Hurtado, MD, received a Clinical Coordinating Center Rally award for outstanding leadership in the CREST-2 trial.
18 Apr 2023
News
Comparison of diuretics shows no difference in heart failure survival
NIH-funded clinical trial underscores need for better treatments for heart failure.
Source: National Institutes of Health
16 Jan 2023
News
Bypass Surgery Has Lower Risks Than Endovascular Therapy for Limb-threatening Ischemia
Bypass surgery in artiries leading to the legs was associated with a lower risk of cardiac events among patients with peripheral arterial disease who are candidates for two types of revascularization therapy, new research suggests.
6 Nov 2022
News
TRANSFORM-HF: Loop Diuretics Show No Difference in Mortality and Hospitalizations for Heart Failure
The results of the TRANSFORM-HF study, which explored the effects of two different therapies on heart failure outcomes, were featured during the first late-breaking session at the American Heart Association Scientific Sessions.
5 Nov 2022
News
No Survival Advantage for Either Torsemide or Furosemide in HF: TRANSFORM-HF
The choice of loop diuretic for decongestion in patients hospitalized with heart failure (HF) may make little difference to survival or readmission risk over the next year, at least when deciding between furosemide or torsemide, a randomized trial suggests.
Source: Medscape
5 Nov 2022
News
How targeted EHR alerts can close practice gaps and improve patient care: insights from an expert at Yale School of Medicine
Although heart disease has long been known a leading cause of morbidity worldwide, it takes too long for evidence-based research to translate into direct patient care when it comes to pharmaceutical therapies.
Source: Becker's Hospital Review
2 Nov 2022
News
Cardiovascular Medicine Grand Rounds Recap: The DISCOVER INOCA Registry
The October 25, 2022, Yale Cardiovascular Medicine Grand Rounds, “Seeing the Invisible: Ischemia and No Obstructive Coronary Artery Disease,” was presented by Samit Shah MD, PhD.
26 Oct 2022
News
Yale University Study Demonstrates Significant Survival Benefit in High-Risk PCI with Impella Support
Outcomes included in-hospital survival, myocardial infarction (MI), cardiogenic shock, stroke, bleeding requiring transfusion, acute kidney injury, index hospitalization length of stay, and costs.
Source: Business Wire
13 Oct 2022
News
Impella heart pumps linked to improved high-risk PCI outcomes
High-risk percutaneous coronary intervention (PCI) with an Impella heart pump is associated with better outcomes, including a significantly higher survival rate, than high-risk PCI with an intra-aortic balloon pump (IABP).
Source: Cardiovascular Business
13 Oct 2022
News
New Research Initiative to Identify Sex-specific Treatment Strategies for Coronary Artery Disease
The prospective multi-center registry will focus on the safety and effectiveness of Shockwave’s intravascular lithotripsy (IVL) technology in female patients.
30 Sep 2022
News
VASCADE Closure Device: Patient Characteristics and Outcomes Similar to Standard of Care
Safety and efficacy after using VASCADE closure device system was comparable with the standard treatment option for patients with severe peripheral artery disease.
22 Sep 2022